TRFK-5 reverses established airway eosinophilia but not established hyperresponsiveness in a murine model of chronic asthma

American Journal of Respiratory and Critical Care Medicine

Volumn 159, Issue 2, 1999, Pages 580-587

  Mathur, Mudit ^b   Herrmann, Karin ^b   Li, Xiantang ^b   Qin, Yimin ^b   Weinstock, Joel ^b   Elliott, David ^b   Monahan, Joseph ^b   Padrid, Philip ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; INTERLEUKIN 5; INTERLEUKIN 5 ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; DRUG EFFICACY; DRUG MECHANISM; EOSINOPHILIA; FEMALE; HISTOPATHOLOGY; INTRAPERITONEAL DRUG ADMINISTRATION; LUNG LAVAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST;

EID: 0000965148     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.159.2.9712018     Document Type: Article

References (41)

1. Martin, L. B., H. Kita, K. M. Leiferman, and G. J. Gleich. 1996. Eosinophils in allergy: role in disease, degranulation, and cytokines. Int. Arch. Allergy Immunol. 109:207-215.
2. + T lymphocytes prevents antigen-induced airway hyperreactivity and pulmonary eosinophilia. Am. J. Respir. Cell Mol. Biol. 10:587-593.
3. Corrigan, C. J., and A. B. Kay. 1990. CD4 T-lymphocyte activation in acute severe asthma: relationship to disease severity and atopic status. Am. Rev. Respir. Dis. 141:970-977.
4. Foster, P. S., S. P. Hogan, A. J. Ramsay, K. I. Matthaei, and I. G. Young. 1996. Interleukin 5 deficiency abolishes eosinophilia airways hyperre activity and lung damage in a mouse asthma model. J. Exp. Med. 183:195-201.
5. Brusselle, G., J. Kips, G. Koos, H. Bluethmann, and R. Pauwels. 1995. Allergen-induced airway inflammation and bronchial responsiveness in wild type and interleukin-4 deficient mice. Am. J. Respir. Cell Mol. Biol. 12:254-259.
6. Gavett, S. H., D. J. O'Hearn, X. Li, S. K. Huang, F. D. Finkelman, and M. Wills-Karp. 1995. Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation and Th2 cytokine expression in mice. J. Exp. Med. 182:1527-1536.
7. Bousquet, J., P. Chanez, J. Y. LaCoste, G. Barneon, N. Ghavanian, I. Enander, P. Venge, S. Ahlstedt, J. Simony-Lafontaine, P. Godard, and F.-B. Michel. 1990. Eosinophil inflammation in asthma. N. Engl. J. Med. 323:1033-1039.
8. Djukanovic, R., J. W. Wilson, K. M. Britten, S. J. Wilson, A. F. Walls, W. R. Roche, P. W. Howarth, and S. T. Holgate. 1992. Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma. Am. Rev. Respir. Dis. 145:669-674.
9. Dunnill, M. S. 1960. The pathology of asthma with special reference to changes in the bronchial mucosa. J. Clin. Pathol. 13:27-33.
10. VanOosterhout, A., A. R. C. Ladenius, H. F. J. Savelkoul, I. V. Ark, K. C. Delsman, and F. P. Nijkamp. 1993. Effect of anti-IL-5 and IL-5 on airway hyperreactivity and eosinophils in guinea pigs. Am. Rev. Respir. Dis. 147:548-552.
11. Nagai, H., S. Yamaguchi, Y. Maeda, and H. Tanaka. 1996. Role of mast cells, eosinophils and IL-5 in the development of airway hyperresponsiveness in sensitized mice. Clin. Exp. Allergy 26:642-647.
12. Hessel, E. M., A. J. Van Oosterhout, I. Van Ark, B. Van Esch, G. Hofman, H. Van Loveran, H. F. Savelkoul, and F. P. Nijkamp. 1997. Development of airway hyperresponsiveness is dependent on interferon gamma and independent of eosinophil infiltration. Am. J. Respir. Cell Mol. Biol. 16:325-334.
13. Lopez, A. F., C. J. Sanderson, J. R. Gamble, H. D. Campbell, I. G. Young, and M. A. Vadas. 1988. Recombinant human interleukin-5 is a selective activator of human eosinophil function. J. Exp. Med. 167:219-224.
14. Yamaguchi, Y., T. Suda, J. Suda, M. Eguchi, Y. Muira, N. Harada, A. Tominaga, and K. Takatsu. 1988. Purified IL-5 supports the terminal differentiation and proliferation of murine eosinophilic precursors. J. Exp. Med. 167:43-56.
15. Yamaguchi, Y., Y. Hayashi, Y. Sugama, Y. Muira, T. Kasahara, S. Kitamura, M. Torisu, S. Mita, A. Tominaga, and K. Takatsu, 1988. Highly purified murine IL-5 stimulates eosinophil function and prolongs in vitro survival IL-5 as an eosinophil chemotactic factor. J. Exp. Med. 167:1737-1742.
16. Ohnishi, T., H. Kita, D. Weiler, S. Sur, J. B. Sedgwick, W. J. Calhoun, W. W. Busse, J. S. Abrams, and G. J. Gleich. 1993. IL-5 is the predominant eosinophil-active cytokine in the antigen-induced pulmonary late-phase reaction. Am. Rev. Respir. Dis. 147:901-907.
17. Robinson, D., Q. Hamid, A. Bentley, S. Ying, A. B. Kay, and S. R. Durham. 1993. Activation of CD4+ T cells, increased T(H2)-type cytokine messenger RNA expression and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthma. J. Allergy Clin. Immunol. 92:313-324.
18. Lee, J. J., M. P. McGarry, S. C. Farmer, K. N. Denzler, K. A. Larson, P. E. Carrigan, I. E. Brenneise, M. A. Horton, A. Haczku, E. W. Gelfand, G. D. Leikauf, and N. A. Lee. 1997. IL-5 expression in the lung epithelium of transgenic mice leads to pulmonary changes pathognomonic of asthma. J. Exp. Med. 185:2143-2146.
19. Hamelmann, E., A. Oshiba, J. Loader, G. L. Larsen, G. Gleich, J. Lee, and E. W. Gelfand. 1997. Anti-interleukin-5 antibody prevents airway hyperresponsiveness in a murine model of airway sensitization. Am. J. Respir. Crit. Care Med. 155:819-825.
20. Mauser, P. J., A. Pitman, A. Witt, X. Fernandez, J. Zurcher, T. Kung, H. Jones, A. S. Watnick, R. W. Egan, and W. Kreutner. 1993. Inhibitory effect of the TRFK-5 anti-IL-5 antibody in a guinea pig model of asthma. Am. Rev. Respir. Dis. 148:1623-1627.
21. Lefort, J., C. M. Bachelet, D. Leduc, and B. B. Vargaftig. 1996. Effect of antigen provocation of IL-5 transgenic mice on eosinophil mobilization and bronchial hyperresponsiveness. J. Allergy Clin. Immunol. 97:788-799.
22. Elliott, D. E. 1996. Methods used to study immunoregulation of schistosome egg granulomas. Immunol. Methods 9:255-267.
23. Padrid, P., M. Mathur, X. Li, K. Herrmann, Y. Qin, A. Cattamanchi, J. Weinstock, D. Elliott, A. Sperling, and J. Bluestone. 1998. CTLA4Ig inhibits airway eosinophilia and hyperresponsiveness by regulating the development of TH1/TH2 subsets in a murine model of asthma. Am. J. Respir. Cell Mol. Biol, 18:453-462.
24. Amdur, M. O., and J. Mead. 1958. Mechanics of respiration in unanesthetized guinea pigs. Am. J. Physiol. 192:364-368.
25. Martin, T. R., N. P. Gerard, S. J. Galli, and J. M. Drazen. 1988. Pulmonary responses to bronchoconstrictor agonists in the mouse. J. Appl. Physiol. 64:2318-2323.
26. Padrid, P. A., P. Cozzi, and A. R. Leff. 1996. Cyclosporine A inhibits airway reactivity and remodeling after chronic antigen challenge in cats. Am. J. Respir. Crit. Care Med. 154:1812-1818.
27. Zar, J. 1984. Biostatistical Analysis, 2nd ed. Prentice Hall, Englewood Cliffs, NJ.
28. Drazen, J. M., J. P. Arm, and K. F. Austen. 1996. Sorting out the cytokines of asthma. J. Exp. Med. 183:1-5.
29. Kung, T., D. M. Stelts, J. A. Zurcher, G. K. Adams, III, R. W. Egan, W. Kreutner, A. S. Watnick, H. Jones, and R. W. Chapman. 1995. Involvement of IL-5 in a murine model of allergic pulmonary inflammation: prophylactic and therapeutic effect of an anti-IL-5 antibody. Am. J. Respir. Cell Mol. Biol. 13:360-365.
30. Garlisi, C. G., A. Falcone, J. A. Hey, T. M. Paster, X. Fernandez, C. A. Rizzo, M. Minnocozzi, H. Jones, M. M. Billah, R. W. Egan, and S. P. Umland. 1997. Airway eosinophils, T cells, Th2-type cytokine mRNA, and hyperreactivity in response to aerosol challenge of allergic mice with previously established pulmonary inflammation. Am. J. Respir. Cell Mol. Biol. 17:642-651.
31. Lilly, C. M., R. Chapman, S. J. Sehring, P. J. Mauser, R. Egan, and J. M. Drazen. 1996. Effects of interleukin-5 induced pulmonary eosinophilia on airway reactivity in the guinea pig. Am. J. Physiol. 270:1368-1375.
32. Hallsworth, M. P., T. M. Litchfield, and T. H. Lee. 1992. Glucocorticoids inhibit GM-CSF and IL-5 enhanced in vitro survival of human eosinophils. Immunology 75:382-385.
33. Schleimer, R. P., and B. S. Bochner. 1994. The effects of glucocorticoids on human eosinophils. J. Allergy Clin. Immunol. 94:1202-1213.
34. Mori, A., M. Suko, Y. Nishizaki, G. Matsuzaki, and H. Okudaira. 1994. Regulation of IL-5 production by peripheral blood mononuclear cells from atopic patients with FK506, cyclosporin A and glucocorticoid. Int. Arch. Allergy Immunol. 104:32-35.
35. Schmidt, J., S. Fleibner, I. Heimann-Weitschat, R. Lindstaedt, and I. Szelenyi. 1994. The effects of different corticosteroids and cyclosporin A on IL-4 and IL-5 release from murine Th2-type T-cells. Eur. J. Pharmacol. 260:247-250.
36. Siebenlist, U., G. Franzuso, and K. Brown. 1994. Structure, regulation and function of NF-kB. Annu. Rev. Cell Biol. 10:405-455.
37. Nijkamp, F. P., R. J. Flower, S. Moncada, and J. R. Vane. 1976. Partial purification of rabbit aorta contracting substance releasing factor and inhibition of its activity by anti inflammatory steroids. Nature 263:479-482.
38. Derksen, F. J., N. E. Robinson, P. J. Armstrong, J. A. Stick, and R. F. Slocombe. 1985. Airway reactivity in ponies with recurrent airway obstruction (heaves). J. Appl. Physiol. 58:598-604.
39. Padrid, P. A. 1995. Animal models of asthma. In S. Liggett and D. Meyers, editors. The Genetics of Asthma, Lung Biology in Health and Disease. Marcel Dekker, New York, 211-235.
40. Busse, W. W., R. L. Coffman, E. W. Gelfand, A. B. Kay, and L. J. Rosenwasser. 1995. Mechanisms of persistent airway inflammation in asthma: a role for T cells and T-cell products. Ant. J. Respir. Crit. Care Med. 152:388-393.
41. Lenschow, D. J., Y. Zeng, J. R. Thistlethwaite, A. Montag, W. Brady, M. G. Gibson, P. S. Linsley, and J. A. Bluestone. 1992. Long term survival of xenogeneic pancreatic islets induced by CTLA4Ig. Science 257:789-792.